ArticleBlood cancer journal2026

Daratumumab ± pomalidomide maintenance after salvage autologous transplantation in relapsed multiple myeloma: a phase 2 study.

Oren Pasvolsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.